UBS Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,590,345
| Closed | -$210M | – | 11205 |
|
|
2025
Q1 | $210M | Buy |
1,590,345
+1,516,876
| +2,065% | +$189M | 0.05% | 480 |
|
|
2024
Q4 | $6.14M | Buy |
73,469
+17,258
| +31% | +$1.42M | ﹤0.01% | 3593 |
|
|
2024
Q3 | $4.11M | Buy |
56,211
+9,107
| +19% | +$684K | ﹤0.01% | 3275 |
|
|
2024
Q2 | $3.23M | Sell |
47,104
-89,892
| -66% | -$6.23M | ﹤0.01% | 3275 |
|
|
2024
Q1 | $9.48M | Buy |
136,996
+2,234
| +2% | +$154K | ﹤0.01% | 2318 |
|
|
2023
Q4 | $9.65M | Buy |
134,762
+90,617
| +205% | +$5.21M | ﹤0.01% | 2128 |
|
|
2023
Q3 | $2.3M | Sell |
44,145
-30,553
| -41% | -$1.78M | ﹤0.01% | 3305 |
|
|
2023
Q2 | $4.73M | Buy |
74,698
+34,924
| +88% | +$2.18M | ﹤0.01% | 2647 |
|
|
2023
Q1 | $2.15M | Buy |
39,774
+10,819
| +37% | +$523K | ﹤0.01% | 3345 |
|
|
2022
Q4 | $1.53M | Buy |
28,955
+26,349
| +1,011% | +$1.32M | ﹤0.01% | 3653 |
|
|
2022
Q3 | $121K | Sell |
2,606
-943
| -27% | -$49.3K | ﹤0.01% | 5538 |
|
|
2022
Q2 | $203K | Sell |
3,549
-57,671
| -94% | -$3.27M | ﹤0.01% | 4897 |
|
|
2022
Q1 | $3.75M | Buy |
61,220
+20,772
| +51% | +$1.08M | ﹤0.01% | 2825 |
|
|
2021
Q4 | $2.12M | Buy |
40,448
+37,098
| +1,107% | +$1.56M | ﹤0.01% | 3690 |
|
|
2021
Q3 | $125K | Sell |
3,350
-9,608
| -74% | -$334K | ﹤0.01% | 5664 |
|
|
2021
Q2 | $529K | Sell |
12,958
-6,504
| -33% | -$240K | ﹤0.01% | 4684 |
|
|
2021
Q1 | $661K | Sell |
19,462
-124
| -0.6% | -$4.3K | ﹤0.01% | 4638 |
|
|
2020
Q4 | $622K | Buy |
19,586
+15,386
| +366% | +$404K | ﹤0.01% | 4422 |
|
|
2020
Q3 | $108K | Sell |
4,200
-16,001
| -79% | -$365K | ﹤0.01% | 5135 |
|
|
2020
Q2 | $518K | Sell |
20,201
-29,794
| -60% | -$603K | ﹤0.01% | 4111 |
|
|
2020
Q1 | $768K | Sell |
49,995
-22,622
| -31% | -$491K | ﹤0.01% | 3577 |
|
|
2019
Q4 | $2.49M | Buy |
72,617
+65,517
| +923% | +$786K | ﹤0.01% | 3327 |
|
|
2019
Q3 | $53K | Sell |
7,100
-1,300
| -15% | -$12.5K | ﹤0.01% | 6169 |
|
|
2019
Q2 | $109K | Sell |
8,400
-3,489
| -29% | -$44.7K | ﹤0.01% | 5319 |
|
|
2019
Q1 | $145K | Buy |
11,889
+2,743
| +30% | +$35K | ﹤0.01% | 4816 |
|
|
2018
Q4 | $104K | Buy |
9,146
+8,546
| +1,424% | +$138K | ﹤0.01% | 5512 |
|
|
2018
Q3 | $13K | Sell |
600
-168
| -22% | -$3.51K | ﹤0.01% | 7045 |
|
|
2018
Q2 | $14K | Sell |
768
-1,193
| -61% | -$24.2K | ﹤0.01% | 6952 |
|
|
2018
Q1 | $41K | Buy |
1,961
+1,361
| +227% | +$26.5K | ﹤0.01% | 5871 |
|
|
2017
Q4 | $9K | Sell |
600
-10,560
| -95% | -$163K | ﹤0.01% | 7109 |
|
|
2017
Q3 | $177K | Sell |
11,160
-3,064
| -22% | -$45K | ﹤0.01% | 4931 |
|
|
2017
Q2 | $176K | Buy |
14,224
+14,124
| +14,124% | +$164K | ﹤0.01% | 4823 |
|
|
2017
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 7315 |
|
|
2016
Q4 | $2K | Sell |
100
-5,964
| -98% | -$84.2K | ﹤0.01% | 7528 |
|
|
2016
Q3 | $93K | Buy |
6,064
+4,129
| +213% | +$167K | ﹤0.01% | 5040 |
|
|
2016
Q2 | $75K | Buy |
1,935
+1,135
| +142% | +$40.8K | ﹤0.01% | 5229 |
|
|
2016
Q1 | $22K | Sell |
800
-1,042
| -57% | -$34.7K | ﹤0.01% | 6139 |
|
|
2015
Q4 | $100K | Buy |
1,842
+1,442
| +361% | +$72.7K | ﹤0.01% | 5212 |
|
|
2015
Q3 | $16K | Sell |
400
-2,436
| -86% | -$79.4K | ﹤0.01% | 6920 |
|
|
2015
Q2 | $91K | Buy |
2,836
+1,838
| +184% | +$46.6K | ﹤0.01% | 5475 |
|
|
2015
Q1 | $24K | Sell |
998
-296
| -23% | -$6.63K | ﹤0.01% | 6805 |
|
|
2014
Q4 | $23K | Buy |
+1,294
| New | +$20.2K | ﹤0.01% | 7452 |
|
Other funds holding ITCI
KIM
HNB